Is the proposal aligned with the goals of the program?
Does the proposal provide clear, strategic thought in describing the problem and the solution?
Does the proposal clearly demonstrate that they have a viable solution that will have clinical impact (within 1-3 year timeframe)?
Is there direct and active participation of clinicians in the development, implementation, and adoption into the clinical workflow?
Are the PI(s) and collaborators well suited to the project? If established, what is their record of accomplishments? Do they have a clear and compelling history of working with others to achieve clinical impact?
Is the institutional support, resources, equipment, and other physical resources available to the investigators adequate for the project proposed?
Criteria to assess significant clinical impact:
Access to clinical data is essential for creation and assessment of decision support tools.
Partnerships with active clinicians with substantial patient caseloads is needed for both the initial determination of feasibility (is the needed data available for patients?) and the longer-term demonstration of accuracy and utility through retrospective and prospective clinical trials.
Scalability – the technology needs to be something easily adaptable and expandable.
How will the project change existing standards of cancer care?
How will the work translate to clinical use/patient care?
